Proposed indications for use factor into FDA panel vote on ReSure Sealant

GAITHERSBURG, Md. — The Ophthalmic Devices Panel of the U.S. Food and Drug Administration affirmed the safety and benefit-risk profile of ReSure Sealant in a September vote.

Full Story →